284 related articles for article (PubMed ID: 21930693)
1. Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore.
Nguyen TT; Stevens MV; Kohr M; Steenbergen C; Sack MN; Murphy E
J Biol Chem; 2011 Nov; 286(46):40184-92. PubMed ID: 21930693
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury.
Panel M; Ruiz I; Brillet R; Lafdil F; Teixeira-Clerc F; Nguyen CT; Calderaro J; Gelin M; Allemand F; Guichou JF; Ghaleh B; Ahmed-Belkacem A; Morin D; Pawlotsky JM
Gastroenterology; 2019 Nov; 157(5):1368-1382. PubMed ID: 31336123
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of cyclophilin D at serine 191 regulates mitochondrial permeability transition pore opening and cell death after ischemia-reperfusion.
Hurst S; Gonnot F; Dia M; Crola Da Silva C; Gomez L; Sheu SS
Cell Death Dis; 2020 Aug; 11(8):661. PubMed ID: 32814770
[TBL] [Abstract][Full Text] [Related]
4. Involvement of mitochondrial permeability transition pore (mPTP) in cardiac arrhythmias: Evidence from cyclophilin D knockout mice.
Gordan R; Fefelova N; Gwathmey JK; Xie LH
Cell Calcium; 2016 Dec; 60(6):363-372. PubMed ID: 27616659
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
Hausenloy DJ; Lim SY; Ong SG; Davidson SM; Yellon DM
Cardiovasc Res; 2010 Oct; 88(1):67-74. PubMed ID: 20400621
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease.
Thomas B; Banerjee R; Starkova NN; Zhang SF; Calingasan NY; Yang L; Wille E; Lorenzo BJ; Ho DJ; Beal MF; Starkov A
Antioxid Redox Signal; 2012 May; 16(9):855-68. PubMed ID: 21529244
[TBL] [Abstract][Full Text] [Related]
7. Cysteine 202 of cyclophilin D is a site of multiple post-translational modifications and plays a role in cardioprotection.
Amanakis G; Sun J; Fergusson MM; McGinty S; Liu C; Molkentin JD; Murphy E
Cardiovasc Res; 2021 Jan; 117(1):212-223. PubMed ID: 32129829
[TBL] [Abstract][Full Text] [Related]
8. Cyclophilin D-mediated Mitochondrial Permeability Transition Regulates Mitochondrial Function.
Zhou S; Yu Q; Zhang L; Jiang Z
Curr Pharm Des; 2023; 29(8):620-629. PubMed ID: 36915987
[TBL] [Abstract][Full Text] [Related]
9. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis.
Jobe SM; Wilson KM; Leo L; Raimondi A; Molkentin JD; Lentz SR; Di Paola J
Blood; 2008 Feb; 111(3):1257-65. PubMed ID: 17989312
[TBL] [Abstract][Full Text] [Related]
10. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia.
Schinzel AC; Takeuchi O; Huang Z; Fisher JK; Zhou Z; Rubens J; Hetz C; Danial NN; Moskowitz MA; Korsmeyer SJ
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12005-10. PubMed ID: 16103352
[TBL] [Abstract][Full Text] [Related]
11. The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation.
Martin LJ; Adams NA; Pan Y; Price A; Wong M
J Neurosci; 2011 Jan; 31(1):359-70. PubMed ID: 21209222
[TBL] [Abstract][Full Text] [Related]
12. Cyclophilin D-mediated regulation of the permeability transition pore is altered in mice lacking the mitochondrial calcium uniporter.
Parks RJ; Menazza S; Holmström KM; Amanakis G; Fergusson M; Ma H; Aponte AM; Bernardi P; Finkel T; Murphy E
Cardiovasc Res; 2019 Feb; 115(2):385-394. PubMed ID: 30165576
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the mitochondrial permeability transition pore in chronic ethanol-mediated liver injury in mice.
King AL; Swain TM; Mao Z; Udoh US; Oliva CR; Betancourt AM; Griguer CE; Crowe DR; Lesort M; Bailey SM
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G265-77. PubMed ID: 24356880
[TBL] [Abstract][Full Text] [Related]
14. Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore.
Elrod JW; Molkentin JD
Circ J; 2013; 77(5):1111-22. PubMed ID: 23538482
[TBL] [Abstract][Full Text] [Related]
15. Complement 1q-binding protein inhibits the mitochondrial permeability transition pore and protects against oxidative stress-induced death.
McGee AM; Baines CP
Biochem J; 2011 Jan; 433(1):119-25. PubMed ID: 20950273
[TBL] [Abstract][Full Text] [Related]
16. The mitochondrial ATP synthase is a negative regulator of the mitochondrial permeability transition pore.
Pekson R; Liang FG; Axelrod JL; Lee J; Qin D; Wittig AJH; Paulino VM; Zheng M; Peixoto PM; Kitsis RN
Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2303713120. PubMed ID: 38091291
[TBL] [Abstract][Full Text] [Related]
17. Genetic deletion of p66shc and/or cyclophilin D results in decreased pulmonary vascular tone.
Gierhardt M; Pak O; Sydykov A; Kraut S; Schäffer J; Garcia C; Veith C; Zeidan EM; Brosien M; Quanz K; Esfandiary A; Saraji A; Hadzic S; Kojonazarov B; Wilhelm J; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F; Herden C; Schulz R; Weissmann N; Heger J; Sommer N
Cardiovasc Res; 2022 Jan; 118(1):305-315. PubMed ID: 33119054
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure.
Lim SY; Hausenloy DJ; Arjun S; Price AN; Davidson SM; Lythgoe MF; Yellon DM
J Cell Mol Med; 2011 Nov; 15(11):2443-51. PubMed ID: 21143389
[TBL] [Abstract][Full Text] [Related]
19. Blocking mitochondrial cyclophilin D ameliorates TSH-impaired defensive barrier of artery.
Liu X; Du H; Chai Q; Jia Q; Liu L; Zhao M; Li J; Tang H; Chen W; Zhao L; Fang L; Gao L; Zhao J
Redox Biol; 2018 May; 15():418-434. PubMed ID: 29353219
[TBL] [Abstract][Full Text] [Related]
20. A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.
Panel M; Ahmed-Belkacem A; Ruiz I; Guichou JF; Pawlotsky JM; Ghaleh B; Morin D
J Pharmacol Exp Ther; 2021 Mar; 376(3):348-357. PubMed ID: 33303698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
